Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

8.59
Delayed Data
As of Mar 28
 -0.30 / -3.37%
Today’s Change
2.48
Today|||52-Week Range
9.25
+35.70%
Year-to-Date

Today’s Trading

Previous close8.89
Today’s open8.88
Day’s range8.58 - 8.99
Volume572,291
Average volume (3 months)1,461,914
Market cap$705.1M
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)-27.12%
Earnings growth (this year)+12.93%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-45.39%
P/E ratioNM
Price/Sales17.70
Price/Book415.61

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd+0.10+0.37%
MYOVMyovant Sciences Ltd-0.52-4.38%
CRSPCRISPR Therapeutics ...+2.18+11.95%
RTRXRetrophin Inc-0.28-1.56%
Data as of 03/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$26.4M
Annual profit (last year)-$55.1M
Net profit margin-209.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts


Search for Jobs